had covid-19 after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (had covid-19 after the second dose) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (had covid-19 after the second dose) (seriousness criterion hospitalization). The patient was hospitalized for 2 days due to COVID-19. At the time of the report, COVID-19 (had covid-19 after the second dose) outcome was unknown.            No concomitant medication information was reported.  Reporter mentioned that their son had COVID-19 after the second dose of the vaccine and before this third dose. He was in hospital and received a drug cocktail (treatment medication), and went home after 2 days.  Company comment: This case concerns an adult male patient with no medical history provided, who experienced COVID-19 which is serious unexpected event of special interest. The patient developed COVID-19 after he had been vaccinated with the second dose of the mRNA-1273 vaccine, however, the precise temporal relationship between vaccination and the reported event cannot be determined as dates were not provided. It was stated that that the patient was hospitalized for two days where he received a drug cocktail (as stated). The outcome of the reported event remained unknown. The re-challenge is not applicable. The event Lack of drug effect (Drug ineffective) was not considered in this specific case report, having in mind the exact time period between the first and the second dose of the mRNA-1273 vaccine was unknown, as well as the temporal relationship between vaccination and the reported event. Based on the current available information, the mRNA-1273 vaccine does not contain a virus capable of causing COVID-19 infection after vaccination, therefore, the causality for COVID-19 is not applicable. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   This case was linked to MOD-2021-418455, MOD-2021-419667 (Patient Link).; Sender's Comments: This case concerns an adult male patient with no medical history provided, who experienced COVID-19 which is serious unexpected event of special interest. The patient developed COVID-19 after he had been vaccinated with the second dose of the mRNA-1273 vaccine, however, the precise temporal relationship between vaccination and the reported event cannot be determined as dates were not provided. It was stated that that the patient was hospitalized for two days where he received a drug cocktail (as stated). The outcome of the reported event remained unknown. The re-challenge is not applicable. The event Lack of drug effect (Drug ineffective) was not considered in this specific case report, having in mind the exact time period between the first and the second dose of the mRNA-1273 vaccine was unknown, as well as the temporal relationship between vaccination and the reported event. Based on the current available information, the mRNA-1273 vaccine does not contain a virus capable of causing COVID-19 infection after vaccination, therefore, the causality for COVID-19 is not applicable. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.